The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
methyl 2-(2-(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazol-3'-yl)ethoxy)-5-((2,4-dioxothiazolidin-5-yl)methyl)benzoate ID: ALA2260189
PubChem CID: 10054486
Max Phase: Preclinical
Molecular Formula: C33H33N5O5S
Molecular Weight: 611.72
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1CCOc1ccc(CC2SC(=O)NC2=O)cc1C(=O)OC
Standard InChI: InChI=1S/C33H33N5O5S/c1-5-8-28-35-29-19(2)15-21(30-34-23-9-6-7-10-24(23)37(30)3)18-25(29)38(28)13-14-43-26-12-11-20(16-22(26)32(40)42-4)17-27-31(39)36-33(41)44-27/h6-7,9-12,15-16,18,27H,5,8,13-14,17H2,1-4H3,(H,36,39,41)
Standard InChI Key: UGCQXMLNDCDBGG-UHFFFAOYSA-N
Molfile:
RDKit 2D
44 49 0 0 0 0 0 0 0 0999 V2000
4.8090 -5.4064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0216 -5.6558 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2933 -6.0838 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8012 -6.7490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0114 -6.4833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1076 -6.0939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9610 -7.5677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3893 -7.0389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3424 -8.1116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5530 -7.8457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5290 -5.3846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3539 -5.3950 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7753 -4.6857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5988 -4.6992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0201 -3.9908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6166 -3.2702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7874 -3.2625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3697 -3.9715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0008 -5.4196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5779 -6.1280 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8257 -5.4317 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.2278 -6.1521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0371 -2.5604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8620 -2.5696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3397 -3.2372 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.1272 -2.9910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1363 -2.1660 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.3547 -1.9025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1070 -1.1155 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.7891 -3.4834 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0698 -4.6237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8780 -4.4582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1388 -3.6755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6064 -6.7787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3811 -8.9357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7391 -9.4465 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0714 -9.3816 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8559 -10.1791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0327 -10.2179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6566 -10.9490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1024 -11.6416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9285 -11.5987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3009 -10.8672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8416 -9.0859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 3 1 0
5 2 1 0
6 3 1 0
7 4 2 0
8 5 2 0
9 7 1 0
10 8 1 0
4 5 1 0
9 10 2 0
6 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
14 19 1 0
19 20 2 0
19 21 1 0
21 22 1 0
16 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 24 1 0
28 29 2 0
26 30 2 0
1 31 1 0
31 32 1 0
32 33 1 0
8 34 1 0
9 35 1 0
36 39 1 0
35 36 2 0
38 37 1 0
37 35 1 0
38 39 2 0
39 40 1 0
40 41 2 0
41 42 1 0
42 43 2 0
43 38 1 0
37 44 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 611.72Molecular Weight (Monoisotopic): 611.2202AlogP: 5.61#Rotatable Bonds: 10Polar Surface Area: 117.34Molecular Species: NEUTRALHBA: 10HBD: 1#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 6.69CX Basic pKa: 5.80CX LogP: 6.09CX LogD: 5.59Aromatic Rings: 5Heavy Atoms: 44QED Weighted: 0.20Np Likeness Score: -0.96
References 1. Chittiboyina AG, Mizuno CS, Desai PV, Patny A, Kurtz TW, Pershadsingh HA, Speth RC, Karamyan V, Avery MA. (2009) Design, synthesis, and docking studies of novel telmisartanglitazone hybrid analogs for the treatment of metabolic syndrome, 18 (7): [10.1007/s00044-008-9152-x ]